Overall survival with abemaciclib in early breast cancer.

Saved in:
Bibliographic Details
Title: Overall survival with abemaciclib in early breast cancer.
Authors: Johnston S; The Royal Marsden NHS Foundation Trust, London, UK. Electronic address: stephen.johnston@rmh.nhs.uk., Martin M; Hospital General Universitario Gregorio Marañon, Universidad Complutense, CIBERONC, GEICAM, Madrid, Spain., O'Shaughnessy J; Baylor University Medical Center, Texas Oncology, US Oncology, Dallas, USA., Hegg R; University of São Paulo and Pérola Centro de Pesquisa em Oncologia, São Paulo, Brazil., Tolaney SM; Dana-Farber Cancer Institute, Boston, USA., Guarneri V; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy., Del Mastro L; Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy; Clinical Oncology Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Campone M; Institut de Cancérologie de l'Ouest, NANTES - ANGERS, France., Sohn J; Yonsei University College of Medicine, Seoul, South Korea., Boyle F; Sydney Medical School, University of Sydney, Sydney, Australia., Cortes J; International Breast Cancer Center (IBCC), Quironsalud Arm, Barcelona, Spain., Rugo HS; City of Hope Comprehensive Cancer Center, Duarte, USA; USCF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, USA., Goetz MP; Mayo Clinic, Rochester, USA., Hamilton EP; Sarah Cannon Research Institute, Nashville, USA., Huang CS; National Taiwan University Hospital, Taipei, Taiwan., Senkus E; Medical University of Gdańsk, Gdańsk, Poland; Breast Unit, University Clinical Center, Gdańsk, Poland., Cicin I; Istinye University, Istanbul, Turkey., Testa L; D'Or Institute for Research and Education (IDOR), São Paulo, Brazil., Neven P; University Hospitals Leuven, Louvain, Belgium., Huober J; HOCH Kantonsspital St. Gallen, St. Gallen, Switzerland., Shao Z; Fudan University Shanghai Cancer Center, Shanghai, China., Wei R; Eli Lilly and Company, Indianapolis, USA., Munoz M; Eli Lilly and Company, Indianapolis, USA., San Antonio B; Eli Lilly and Company, Indianapolis, USA., Shahir A; Eli Lilly and Company, Indianapolis, USA., Rastogi P; UPMC Hillman Cancer Center and NSABP Foundation, Pittsburgh, USA., Harbeck N; Brustzentrum, Frauenklinik and CCC Munich, LMU University Hospital, Munich, Germany.
Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2026 Feb; Vol. 37 (2), pp. 155-165. Date of Electronic Publication: 2025 Oct 17.
Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41110697
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Overall survival with abemaciclib in early breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Johnston+S%22">Johnston S</searchLink>; The Royal Marsden NHS Foundation Trust, London, UK. Electronic address: stephen.johnston@rmh.nhs.uk.<br /><searchLink fieldCode="AU" term="%22Martin+M%22">Martin M</searchLink>; Hospital General Universitario Gregorio Marañon, Universidad Complutense, CIBERONC, GEICAM, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22O'Shaughnessy+J%22">O'Shaughnessy J</searchLink>; Baylor University Medical Center, Texas Oncology, US Oncology, Dallas, USA.<br /><searchLink fieldCode="AU" term="%22Hegg+R%22">Hegg R</searchLink>; University of São Paulo and Pérola Centro de Pesquisa em Oncologia, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Tolaney+SM%22">Tolaney SM</searchLink>; Dana-Farber Cancer Institute, Boston, USA.<br /><searchLink fieldCode="AU" term="%22Guarneri+V%22">Guarneri V</searchLink>; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy.<br /><searchLink fieldCode="AU" term="%22Del+Mastro+L%22">Del Mastro L</searchLink>; Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy; Clinical Oncology Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.<br /><searchLink fieldCode="AU" term="%22Campone+M%22">Campone M</searchLink>; Institut de Cancérologie de l'Ouest, NANTES - ANGERS, France.<br /><searchLink fieldCode="AU" term="%22Sohn+J%22">Sohn J</searchLink>; Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Boyle+F%22">Boyle F</searchLink>; Sydney Medical School, University of Sydney, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Cortes+J%22">Cortes J</searchLink>; International Breast Cancer Center (IBCC), Quironsalud Arm, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Rugo+HS%22">Rugo HS</searchLink>; City of Hope Comprehensive Cancer Center, Duarte, USA; USCF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, USA.<br /><searchLink fieldCode="AU" term="%22Goetz+MP%22">Goetz MP</searchLink>; Mayo Clinic, Rochester, USA.<br /><searchLink fieldCode="AU" term="%22Hamilton+EP%22">Hamilton EP</searchLink>; Sarah Cannon Research Institute, Nashville, USA.<br /><searchLink fieldCode="AU" term="%22Huang+CS%22">Huang CS</searchLink>; National Taiwan University Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Senkus+E%22">Senkus E</searchLink>; Medical University of Gdańsk, Gdańsk, Poland; Breast Unit, University Clinical Center, Gdańsk, Poland.<br /><searchLink fieldCode="AU" term="%22Cicin+I%22">Cicin I</searchLink>; Istinye University, Istanbul, Turkey.<br /><searchLink fieldCode="AU" term="%22Testa+L%22">Testa L</searchLink>; D'Or Institute for Research and Education (IDOR), São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Neven+P%22">Neven P</searchLink>; University Hospitals Leuven, Louvain, Belgium.<br /><searchLink fieldCode="AU" term="%22Huober+J%22">Huober J</searchLink>; HOCH Kantonsspital St. Gallen, St. Gallen, Switzerland.<br /><searchLink fieldCode="AU" term="%22Shao+Z%22">Shao Z</searchLink>; Fudan University Shanghai Cancer Center, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Wei+R%22">Wei R</searchLink>; Eli Lilly and Company, Indianapolis, USA.<br /><searchLink fieldCode="AU" term="%22Munoz+M%22">Munoz M</searchLink>; Eli Lilly and Company, Indianapolis, USA.<br /><searchLink fieldCode="AU" term="%22San+Antonio+B%22">San Antonio B</searchLink>; Eli Lilly and Company, Indianapolis, USA.<br /><searchLink fieldCode="AU" term="%22Shahir+A%22">Shahir A</searchLink>; Eli Lilly and Company, Indianapolis, USA.<br /><searchLink fieldCode="AU" term="%22Rastogi+P%22">Rastogi P</searchLink>; UPMC Hillman Cancer Center and NSABP Foundation, Pittsburgh, USA.<br /><searchLink fieldCode="AU" term="%22Harbeck+N%22">Harbeck N</searchLink>; Brustzentrum, Frauenklinik and CCC Munich, LMU University Hospital, Munich, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229007735%22">Annals of oncology : official journal of the European Society for Medical Oncology</searchLink> [Ann Oncol] 2026 Feb; Vol. 37 (2), pp. 155-165. <i>Date of Electronic Publication: </i>2025 Oct 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9007735 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1569-8041 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209237534%22">09237534 </searchLink><i>NLM ISO Abbreviation: </i>Ann Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41110697
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2025.10.005
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 155
    Titles:
      – TitleFull: Overall survival with abemaciclib in early breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Johnston S
      – PersonEntity:
          Name:
            NameFull: Martin M
      – PersonEntity:
          Name:
            NameFull: O'Shaughnessy J
      – PersonEntity:
          Name:
            NameFull: Hegg R
      – PersonEntity:
          Name:
            NameFull: Tolaney SM
      – PersonEntity:
          Name:
            NameFull: Guarneri V
      – PersonEntity:
          Name:
            NameFull: Del Mastro L
      – PersonEntity:
          Name:
            NameFull: Campone M
      – PersonEntity:
          Name:
            NameFull: Sohn J
      – PersonEntity:
          Name:
            NameFull: Boyle F
      – PersonEntity:
          Name:
            NameFull: Cortes J
      – PersonEntity:
          Name:
            NameFull: Rugo HS
      – PersonEntity:
          Name:
            NameFull: Goetz MP
      – PersonEntity:
          Name:
            NameFull: Hamilton EP
      – PersonEntity:
          Name:
            NameFull: Huang CS
      – PersonEntity:
          Name:
            NameFull: Senkus E
      – PersonEntity:
          Name:
            NameFull: Cicin I
      – PersonEntity:
          Name:
            NameFull: Testa L
      – PersonEntity:
          Name:
            NameFull: Neven P
      – PersonEntity:
          Name:
            NameFull: Huober J
      – PersonEntity:
          Name:
            NameFull: Shao Z
      – PersonEntity:
          Name:
            NameFull: Wei R
      – PersonEntity:
          Name:
            NameFull: Munoz M
      – PersonEntity:
          Name:
            NameFull: San Antonio B
      – PersonEntity:
          Name:
            NameFull: Shahir A
      – PersonEntity:
          Name:
            NameFull: Rastogi P
      – PersonEntity:
          Name:
            NameFull: Harbeck N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2026 Feb
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1569-8041
          Numbering:
            – Type: volume
              Value: 37
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Annals of oncology : official journal of the European Society for Medical Oncology
              Type: main
ResultId 1